By Sindhu Sundar ( February 26, 2015, 4:18 PM EST) -- A New York federal judge on Thursday declined to review a suit against Eli Lilly & Co. over the labeling of its antidepressant Cymbalta that allegedly downplays its withdrawal symptoms, finding that the plaintiff had not introduced any new evidence that warranted a new look at the case....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.